Medicare Enrolled

Dr. Joaquin Maury Ochoa, M.D

Neurology · Miami, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
8200 SW 117TH AVE STE 416, Miami, FL 33183
7864097662
In practice since 2009 (17 years)
NPI: 1477795813 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Maury Ochoa from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Maury Ochoa? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Maury Ochoa

Dr. Joaquin Maury Ochoa is a neurology in Miami, FL, with 17 years in practice. Based on federal Medicare data, Dr. Maury Ochoa performed 448 Medicare services across 299 unique beneficiaries.

Between the years covered by Open Payments, Dr. Maury Ochoa received a total of $12,937 from 59 pharmaceutical and/or device companies across 461 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Maury Ochoa is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice▲ 448 Medicare services$ $12,937 industry payments

Medicare Practice Summary

Medicare Utilization ↗
448
Medicare services
Bottom 46% in FL for neurology
299
Unique beneficiaries
$97
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~26 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)159$99$182
Office visit, established patient, complex (40-54 min)81$140$234
Steroid injection (triamcinolone)65$1$4
New patient office visit (45-59 min)33$142$266
Dexamethasone injection (steroid)26$0$6
Nerve conduction, 9-10 studies23$174$380
Needle measurement of electrical activity in arm or leg muscles, limited study21$74$94
Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance14$165$259
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level13$200$354
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level13$87$150
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$12,937
Total received (2018-2024)
Avg $1,848/year across 7 years
Top 24% in FL for neurology
59
Companies
461
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,925 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,235
2023
$2,145
2022
$1,494
2021
$1,610
2020
$2,389
2019
$1,712
2018
$1,351

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$1,814
UCB, Inc.
$1,444
ABBVIE INC.
$982
Nevro Corp.
$685
SK Life Science, Inc.
$569
Novartis Pharmaceuticals Corporation
$553
Stimwave Technologies Incorporated
$503
Teva Pharmaceuticals USA, Inc.
$488
GE HEALTHCARE
$455
Biogen, Inc.
$443
Amneal Pharmaceuticals LLC
$359
EMD Serono, Inc.
$340
Biohaven Pharmaceuticals, Inc.
$330
Abbott Laboratories
$308
Medtronic Vascular, Inc.
$303
Medtronic USA, Inc.
$285
Lilly USA, LLC
$281
GE HealthCare
$254
Allergan, Inc.
$203
PFIZER INC.
$177
Vertos Medical, Inc.
$169
BANNER LIFE SCIENCES, LLC
$145
Genentech USA, Inc.
$138
Alexion Pharmaceuticals, Inc.
$134
Nalu Medical, Inc.
$125
Biohaven Pharmaceutical Holding Company Ltd.
$115
Scilex Pharmaceuticals Inc.
$114
SCILEX PHARMACEUTICALS INC.
$72
Amgen Inc.
$70
ACADIA Pharmaceuticals Inc
$62
ARGENX US, INC.
$62
SPR Therapeutics, Inc
$58
Neurocrine Biosciences, Inc.
$56
AbbVie Inc.
$55
Avion Pharmaceuticals
$54
Aprecia Pharmaceuticals, LLC
$51
MITSUBISHI TANABE PHARMA AMERICA, INC.
$48
Alnylam Pharmaceuticals Inc.
$46
Kyowa Kirin, Inc.
$45
Neurelis, Inc.
$45
Lundbeck LLC
$43
GENZYME CORPORATION
$41
SI-BONE, INC.
$39
BOSTON SCIENTIFIC CORPORATION
$38
Kowa Pharmaceuticals America, Inc.
$37
Saluda Medical Americas, Inc.
$36
IMPEL PHARMACEUTICALS INC.
$32
TG THERAPEUTICS, INC.
$25
TG Therapeutics, Inc.
$25
Otsuka America Pharmaceutical, Inc.
$24
Merz Pharmaceuticals, LLC
$23
GRT US Holding, Inc.
$22
Zyla Life Sciences, Inc.
$19
Eisai Inc.
$18
Banner Life Sciences, LLC
$17
ARBOR PHARMACEUTICALS, INC.
$15
Arbor Pharmaceuticals, Inc.
$15
Allergan Inc.
$14
ASSERTIO THERAPEUTICS, INC.
$13
Top 3 companies account for 32.8% of total payments
Associated products mentioned in payments ›
ADAPTIVESTIM · ADUHELM · AIMOVIG · AJOVY · AMYVID · AUBAGIO · AUSTEDO · Aimovig · Arctic Front · Austedo XR · BAFIERTAM · BOTOX · BRIUMVI · Briviact · COMIRNATY · Cambia · DaTscan · Dhivy · EMGALITY · Evoke SCS · GIVLAARI · Horizant · INGREZZA · INTELLIS · Intracept · KESIMPTA · KISUNLA · Leqembi · MAVENCLAD · Mavenclad · MyCareLink · NUPLAZID · NURTEC ODT · Nalu Neurostimulation System · Nourianz · OCREVUS · ONGENTYS · ONPATTRO · Octrode SCS Leads · Omnia · PAXLOVID · Proclaim Family of SCS IPGs · QULIPTA · Qutenza · RADICAVA · REXULTI · REYVOW · RYTARY · Rystiggo · SCS leads · SEGLENTIS · SOLIRIS · SPECTRA WAVEWRITER · SPRINT PNS System · SPRIX · SUPERION · Seglentis · Senza · Senza Spinal Cord Stimulation System · Spritam · Superion · Superion Indirect Decompression System · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VUMERITY · VYVGART · VYVGART HYTRULO · Vimpat · Xeomin · ZTLido · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $2,888 per 100 Medicare services performed
Looking for a neurology in Miami?
Compare neurologys in the Miami area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
251
Per 100K population
9.3
County median income
$68,694
Nearest hospital
HCA FLORIDA KENDALL HOSPITAL
2.5 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Maury Ochoa is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Maury Ochoa experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Maury Ochoa performed 159 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Maury Ochoa receive payments from pharmaceutical companies?
Yes. Dr. Maury Ochoa received a total of $12,937 from 59 companies across 461 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Maury Ochoa's costs compare to other neurologys in Miami?
Dr. Maury Ochoa's average Medicare payment per service is $97. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Maury Ochoa) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →